Published in Am J Med on January 01, 2001
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA (2009) 5.63
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study. Circulation (2009) 1.16
T wave abnormalities, high body mass index, current smoking and high lipoprotein (a) levels predict the development of major abnormal Q/QS patterns 20 years later. A population-based study. BMC Cardiovasc Disord (2006) 0.79
The relationship between Lp(a) and CVD outcomes: a systematic review. Lipids Health Dis (2016) 0.76
Lipoprotein measurements--setting priorities. Am J Med (2001) 0.75
Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction. Heart Vessels (2016) 0.75
Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet (1975) 9.00
Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet (1986) 6.51
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis (2000) 4.88
Short tandem repeat profiling provides an international reference standard for human cell lines. Proc Natl Acad Sci U S A (2001) 4.84
Coronary heart disease in south Asians overseas: a review. J Clin Epidemiol (1989) 4.53
Errors in the polymerase chain reaction. Nucleic Acids Res (1988) 3.52
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet (1993) 3.03
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res (1982) 3.02
Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects. Circulation (2005) 2.77
Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol (2003) 2.63
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet (2001) 2.44
Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study. BMJ (2000) 2.40
Electrophoresis for genotyping: microtiter array diagonal gel electrophoresis on horizontal polyacrylamide gels, hydrolink, or agarose. Anal Biochem (1994) 2.38
Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem (1996) 2.36
Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation (2001) 2.29
The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J (2001) 2.21
Serum lipoproteins and susceptibility of men of Indian descent to coronary heart disease. The St James Survey, Trinidad. Lancet (1982) 2.11
Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet (2008) 2.05
High total and cardiovascular disease mortality in adults of Indian descent in Trinidad, unexplained by major coronary risk factors. Lancet (1986) 2.04
Antithrombin III and arterial disease. Lancet (1991) 1.98
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
Letter: High-density lipoprotein and atherosclerosis. Lancet (1975) 1.93
Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J Thromb Haemost (2004) 1.91
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis (2000) 1.90
Ethnic variation in forced expiratory volume and forced vital capacity of African and Indian adults in Guyana. Am Rev Respir Dis (1970) 1.87
Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations. Lancet (1987) 1.85
Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J (2000) 1.83
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80
Human gene for physical performance. Nature (1998) 1.78
Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet (2006) 1.76
Vigorous exercise in leisure time, coronary risk-factors, and resting electrocardiogram in middle-aged male civil servants. Br Heart J (1976) 1.69
Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII). J Thromb Haemost (2007) 1.67
Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis. J Biol Chem (2001) 1.65
A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet (1985) 1.64
Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol (1999) 1.63
The isolation of a clone for human alpha 1-antitrypsin and the detection of alpha 1-antitrypsin in mRNA from liver and leukocytes. Biochem Biophys Res Commun (1983) 1.62
A study of DNA polymorphisms around the human apolipoprotein AI gene in hyperlipidaemic and normal individuals. Clin Genet (1985) 1.62
The same normal cell protein is phosphorylated after transformation by avian sarcoma viruses with unrelated transforming genes. Mol Cell Biol (1981) 1.59
There are approximately 20 actin gene in the human genome. Nucleic Acids Res (1981) 1.58
Risk of fatal stroke in patients with treated familial hypercholesterolemia: a prospective registry study. Stroke (2003) 1.57
Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines. Cancer Res (1998) 1.57
TSU-Pr1 and JCA-1 cells are derivatives of T24 bladder carcinoma cells and are not of prostatic origin. Cancer Res (2001) 1.55
Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects. Diabetologia (2000) 1.54
Isolation and characterisation of a cDNA clone for human apolipoprotein CI and assignment of the gene to chromosome 19. Hum Genet (1985) 1.53
Haemostatic changes that constitute the hypercoagulable state. Lancet (1991) 1.47
Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol (1994) 1.47
Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine (2000) 1.46
Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res (2002) 1.46
Epidemiological characteristics of platelet aggregability. Br Med J (Clin Res Ed) (1985) 1.42
Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J (1995) 1.41
Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet (1986) 1.41
The ACE gene and muscle performance. Nature (2000) 1.40
Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab (2003) 1.38
An assessment of lung volumes and gas transfer in sickle-cell anaemia. Thorax (1971) 1.38
Characteristics relevant to cardiovascular disease among adults of African and Indian origin in Guyana. Bull World Health Organ (1970) 1.37
Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol (2000) 1.36
The light-harvesting chlorpohyll-protein complex of photosystem II. Its location in the photosynthetic membrane. J Cell Biol (1976) 1.34
The lipoid pneumonia of blackfat tobacco smokers in Guyana. Q J Med (1971) 1.32
Lung function of healthy boys and girls in Jamaica in relation to ethnic composition, test exercise performance, and habitual physical activity. Thorax (1977) 1.30
High density lipoproteins and atherosclerosis. Annu Rev Med (1980) 1.30
HOX genes in human lung: altered expression in primary pulmonary hypertension and emphysema. Am J Pathol (2001) 1.29
Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project. Clin Genet (2010) 1.29
INSIG2 gene polymorphism is not associated with obesity in Caucasian, Afro-Caribbean and Indian subjects. Int J Obes (Lond) (2007) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet (2004) 1.27
Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Ann Hum Genet (2003) 1.27
High-density lipoprotein composition is altered by a common DNA polymorphism adjacent to apoprotein AII gene in man. Lancet (1985) 1.26
Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur J Vasc Endovasc Surg (2007) 1.25
Histopathology of malignant lesions of the penis. Urol Clin North Am (1992) 1.25
Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1995) 1.24
Positive associations between single nucleotide polymorphisms in the IGF2 gene region and body mass index in adult males. Hum Mol Genet (2001) 1.23
Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis (1997) 1.22
A common restriction fragment length polymorphism of the human apolipoprotein E gene and its relationship to type III hyperlipidaemia. Hum Genet (1987) 1.21
Description of a dinucleotide repeat polymorphism in the human elastin gene and its use to confirm assignment of the gene to chromosome 7. Ann Hum Genet (1993) 1.20
beta-Adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab (2001) 1.19
Molecular analysis of multifocal prostate cancer lesions. J Pathol (1999) 1.19
Computer modeling of prostate biopsy: tumor size and location--not clinical significance--determine cancer detection. J Urol (1998) 1.18
Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat (1997) 1.18
The isolation of a genomic clone containing the apolipoprotein CII gene and the detection of linkage disequilibrium between two common DNA polymorphisms around the gene. Hum Genet (1984) 1.18
Steroid hormone induction and expression patterns of L-plastin in normal and carcinomatous prostate tissues. Am J Pathol (1997) 1.18
Recognizing phosphatidylinositol 3-phosphate. Cell (2001) 1.18
Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. J Lipid Res (1999) 1.17
Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia. Heart (2004) 1.17
Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality. Atherosclerosis (1986) 1.17
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism (2004) 1.17
EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis (2005) 1.17
The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4. Ann Hum Genet (2005) 1.15
Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart (2011) 1.15
Polymorphisms at the apoB, apoA-I, and cholesteryl ester transfer protein gene loci in patients with gallbladder disease. J Lipid Res (1995) 1.14
The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis. Eur Heart J (2002) 1.14
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia (2006) 1.14
Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease. Atherosclerosis (2006) 1.13
Truncated variants of apolipoprotein B cause hypobetalipoproteinaemia. Nucleic Acids Res (1988) 1.13